| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $702M | — | — | — | — |
| Op. Income | $45M | — | — | — | — |
| Gross Margin | 16.6% | — | — | — | — |
| Net Margin | 1.3% | — | — | — | — |
| EPS (Diluted) | $0.37 | — | — | — | — |
| Free Cash Flow | $151M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $702M |
| Cost of Revenue | $586M |
| GROSS PROFIT | $117M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $72M |
| Other Expenses | $0 |
| Operating Expenses | $72M |
| Cost & Expenses | $658M |
| OPERATING INCOME | $45M |
| Interest Income | $2M |
| Interest Expense | $20M |
| Other Income/Expenses | -$24M |
| INCOME BEFORE TAX | $21M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $14M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $9M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $9M |
| D&A | $15M |
| EBIT | $40M |
| EBITDA | $56M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $702M |
| Cost of Revenue | $586M |
| GROSS PROFIT | $117M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $72M |
| Other Expenses | $0 |
| Operating Expenses | $72M |
| Cost & Expenses | $658M |
| OPERATING INCOME | $45M |
| Interest Income | $2M |
| Interest Expense | $20M |
| Other Income/Expenses | -$24M |
| INCOME BEFORE TAX | $21M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $14M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $9M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $9M |
| D&A | $15M |
| EBIT | $40M |
| EBITDA | $56M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $9M |
| Depreciation & Amortization | $15M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $5M |
| Other Non-Cash Items | $19M |
| Change in Working Capital | $110M |
| OPERATING CASH FLOW | $159M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | $2M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$6M |
| Net Debt Issuance | -$83M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$20M |
| Other Financing Activities | -$5M |
| NET CASH FROM FINANCING | -$108M |
| FREE CASH FLOW | $151M |
| Net Change in Cash | $45M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $260M |
| Short-Term Investments | $0 |
| Net Receivables | $633M |
| Inventory | $1.2B |
| Other Current Assets | $78M |
| TOTAL CURRENT ASSETS | $2.2B |
| PP&E (Net) | $407M |
| Goodwill | $214M |
| Intangible Assets | $58M |
| Long-Term Investments | $81M |
| Tax Assets | $17M |
| Other Non-Current Assets | $57M |
| TOTAL NON-CURRENT ASSETS | $833M |
| TOTAL ASSETS | $3.0B |
| Account Payables | $98M |
| Short-Term Debt | $455M |
| Deferred Revenue | $4M |
| Other Current Liabilities | $45M |
| TOTAL CURRENT LIABILITIES | $750M |
| Long-Term Debt | $618M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $42M |
| Other Non-Current Liabilities | $58M |
| TOTAL NON-CURRENT LIABILITIES | $739M |
| TOTAL LIABILITIES | $1.5B |
| Common Stock | $352M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $1.2B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$80M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.5B |
| Minority Interest | $42M |
| TOTAL EQUITY | $1.5B |
| TOTAL LIABILITIES & EQUITY | $3.0B |
| Total Debt | $1.1B |
| Net Debt | $844M |
